Honoring Tom Racobaldo: Crothall CEO to Retire After Decades of Leadership

Honoring Tom Racobaldo: Crothall CEO to Retire After Decades of Leadership  In 1979, Tom Racobaldo refinished hospital floors and cleaned patient rooms as a Crothall management trainee. Six months later, he received his first assignment: managing a 50-bed hospital with 10 employees in northeast Philadelphia.  Forty-six years later, Racobaldo will retire as Crothall’s chief executive officer. Well-known for his humility, Racobaldo will complete nearly a half-century in the business at the top…

Read More

Walmart Expands Centers of Excellence Benefit To Include All Cancers

Walmart’s Cancer Centers of Excellence program historically focused on some of the most prevalent cancers, such as breast, lung, colon, prostate, pancreatic and blood cancer. Now, employees can access the same benefit for a whole host of other cancers, including bone, pituitary, liver, thyroid, central nervous system and gynecological. The post Walmart Expands Centers of…

Read More

Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target

Gilead Sciences is acquiring LEO Pharma’s oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Morgan Healthcare Conference. The post Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt…

Read More